BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38181121)

  • 21. When to perform bone scan in patients with newly diagnosed prostate cancer: external validation of the currently available guidelines and proposal of a novel risk stratification tool.
    Briganti A; Passoni N; Ferrari M; Capitanio U; Suardi N; Gallina A; Da Pozzo LF; Picchio M; Di Girolamo V; Salonia A; Gianolli L; Messa C; Rigatti P; Montorsi F
    Eur Urol; 2010 Apr; 57(4):551-8. PubMed ID: 20034730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Machine learning for microbial identification and antimicrobial susceptibility testing on MALDI-TOF mass spectra: a systematic review.
    Weis CV; Jutzeler CR; Borgwardt K
    Clin Microbiol Infect; 2020 Oct; 26(10):1310-1317. PubMed ID: 32217160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Profiling protein markers associated with lymph node metastasis in prostate cancer by DIGE-based proteomics analysis.
    Pang J; Liu WP; Liu XP; Li LY; Fang YQ; Sun QP; Liu SJ; Li MT; Su ZL; Gao X
    J Proteome Res; 2010 Jan; 9(1):216-26. PubMed ID: 19894759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and posttreatment head and neck cancer samples.
    Freed GL; Cazares LH; Fichandler CE; Fuller TW; Sawyer CA; Stack BC; Schraff S; Semmes OJ; Wadsworth JT; Drake RR
    Laryngoscope; 2008 Jan; 118(1):61-8. PubMed ID: 18043497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MALDI MS profiling of post-DRE urine samples highlights the potential of β-microseminoprotein as a marker for prostatic diseases.
    Flatley B; Wilmott KG; Malone P; Cramer R
    Prostate; 2014 Jan; 74(1):103-11. PubMed ID: 24115268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapid identification of Mycobacterium avium clinical isolates by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Lin CS; Su CC; Hsieh SC; Lu CC; Wu TL; Jia JH; Wu TS; Han CC; Tsai WC; Lu JJ; Lai HC
    J Microbiol Immunol Infect; 2015 Apr; 48(2):205-12. PubMed ID: 24113069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Detection of Serum Peptides in Patients with Lung Squamous Cell Carcinoma by MALDI-TOF-MS and Analysis of Their Correlation with Chemotherapy Efficacy].
    Zhao G; Xu B; Li X; Tang C; Qin H; Wang H; Yang S; Wang W; Gao H; He K; Liu X
    Zhongguo Fei Ai Za Zhi; 2017 May; 20(5):318-325. PubMed ID: 28532539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of pre-neoplastic and neoplastic prostate disease by MALDI profiling of urine.
    M'Koma AE; Blum DL; Norris JL; Koyama T; Billheimer D; Motley S; Ghiassi M; Ferdowsi N; Bhowmick I; Chang SS; Fowke JH; Caprioli RM; Bhowmick NA
    Biochem Biophys Res Commun; 2007 Feb; 353(3):829-34. PubMed ID: 17194448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiomic-based machine learning model for the accurate prediction of prostate cancer risk stratification.
    Shu X; Liu Y; Qiao X; Ai G; Liu L; Liao J; Deng Z; He X
    Br J Radiol; 2023 Mar; 96(1143):20220238. PubMed ID: 36475858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A 17-gene assay to predict prostate cancer aggressiveness in the context of Gleason grade heterogeneity, tumor multifocality, and biopsy undersampling.
    Klein EA; Cooperberg MR; Magi-Galluzzi C; Simko JP; Falzarano SM; Maddala T; Chan JM; Li J; Cowan JE; Tsiatis AC; Cherbavaz DB; Pelham RJ; Tenggara-Hunter I; Baehner FL; Knezevic D; Febbo PG; Shak S; Kattan MW; Lee M; Carroll PR
    Eur Urol; 2014 Sep; 66(3):550-60. PubMed ID: 24836057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid identification and discrimination of methicillin-resistant Staphylococcus aureus strains via matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Liu X; Su T; Hsu YS; Yu H; Yang HS; Jiang L; Zhao Z
    Rapid Commun Mass Spectrom; 2021 Jan; 35(2):e8972. PubMed ID: 33053243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry.
    Seng P; Drancourt M; Gouriet F; La Scola B; Fournier PE; Rolain JM; Raoult D
    Clin Infect Dis; 2009 Aug; 49(4):543-51. PubMed ID: 19583519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identifying High Gleason Score Prostate Cancer by Prostate Fluid Metabolic Fingerprint-Based Multi-Modal Recognition.
    Peng Z; Wang Y; Wu X; Yang S; Du X; Xu X; Hu C; Liu W; Zhu Y; Dong B; Pan J; Bao Q; Qian K; Dong L; Xue W
    Small Methods; 2024 Jan; ():e2301684. PubMed ID: 38258603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accurate classification of Listeria species by MALDI-TOF mass spectrometry incorporating denoising autoencoder and machine learning.
    Li Y; Gan Z; Zhou X; Chen Z
    J Microbiol Methods; 2022 Jan; 192():106378. PubMed ID: 34818574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fine Needle Aspiration Combined With Matrix-assisted Laser Desorption Ionization Time-of-Flight/Mass Spectrometry to Characterize Lipid Biomarkers for Diagnosing Accuracy of Breast Cancer.
    Cho YT; Su H; Chiang YY; Shiea J; Yuan SF; Hung WC; Yeh YT; Hou MF
    Clin Breast Cancer; 2017 Aug; 17(5):373-381.e1. PubMed ID: 28648841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostate Cancer Risk Calculator Apps in a Taiwanese Population Cohort: Validation Study.
    Chen IA; Chu CH; Lin JT; Tsai JY; Yu CC; Sridhar AN; Sooriakumaran P; Loureiro RCV; Chand M
    J Med Internet Res; 2020 Dec; 22(12):e16322. PubMed ID: 33337340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel algorithm for the prediction of prostate cancer in clinically suspected patients.
    Gallotta A; Ziglioli F; Ferretti S; Maestroni U; Moretti M; Aloe R; Gnocchi C; Di Palo M; Fassina G
    Cancer Biomark; 2013; 13(4):227-34. PubMed ID: 24240583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. When to perform bone scan in patients with newly diagnosed prostate cancer: external validation of a novel risk stratification tool.
    De Nunzio C; Leonardo C; Franco G; Esperto F; Brassetti A; Simonelli G; Dente D; De Dominicis C; Tubaro A
    World J Urol; 2013 Apr; 31(2):365-9. PubMed ID: 22576696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinically Applicable System for Rapidly Predicting Enterococcus faecium Susceptibility to Vancomycin.
    Wang HY; Chung CR; Chen CJ; Lu KP; Tseng YJ; Chang TH; Wu MH; Huang WT; Lin TW; Liu TP; Lee TY; Horng JT; Lu JJ
    Microbiol Spectr; 2021 Dec; 9(3):e0091321. PubMed ID: 34756065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of Prostate Cancer: External Validation of the ERSPC Risk Calculator in a Contemporary Dutch Clinical Cohort.
    Gayet M; Mannaerts CK; Nieboer D; Beerlage HP; Wijkstra H; Mulders PFA; Roobol MJ
    Eur Urol Focus; 2018 Mar; 4(2):228-234. PubMed ID: 28753781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.